BioNeutra International : 07/31/2022 3rd Quarter Report

BioNeutra International, Ltd.

Unaudited Financial Statements of

BioNeutra International, Ltd.

(Formerly Supervision Entertainment, Inc.)

For the quarter ended July 31, 2022 and April 30, 2022

Unaudited financial statements

T A B L E O F C O N T E N T S

Balance Sheets	3
Statements of Operations	4
Statements of Stockholders' Deficit	5
Statements of Cash Flows	6
Notes to the Financial Statements	7

Unaudited financial statements

BioNeutra International, Ltd.

(Formerly Supervision Entertainment, Inc.) Balance Sheets (Unaudited)

		July 31		April 30
		2022		2022
Assets
Current assets:
Cash	$	80	$	5,751
Total current assets	$	80	$	5,751
Property and equipment, net	$	-	$	-
Total assets	$	80	$	5,751
Liabilities and Stockholders' Equity
Accounts payable		139,296		132,348
Accrued liabilities		5,000		5,000
Related parties	$	122,196	$	108,696
Total current liabilities	$	266,492	$	246,044
Stockholders' equity:
Preferred stock, $.0001 par value: 10,000,000 shares authorized;
no shares issued and outstanding.
Common stock, $.0001 par value: 1,000,000,000 shares authorized;
163,429,806 shares outstanding.		16,133		16,133
Treasury stock, 1,000,000 shares outstanding.		(100)		(100)
Capital in excess of par				-
Additional paid-in capital		7,003,009	7,003,009
Accumulated deficit		(7,285,453)	(7,259,334)
Total stockholders' equity		(266,411)		(240,292)
Total liabilities and stockholders' equity		80		5,752

See the accompanying notes to unaudited financial statements.

3

Unaudited financial statements

BioNeutra International, Ltd.

(Formerly Supervision Entertainment, Inc.) Statements of Operations

For the Quarter Ended

	July 31	April 30
	2022	2022
Revenue	-
Operating expenses:
Total operating expenses	19,170	5,080
Loss from operations	(19,170)	(5,080)
Other income (expenses):
Interest expenses	(6,948)	-
Total other income(expense)	(6,948)	-
Profit before provision for income taxes	(26,119)	(5,080)
Provision for income taxes	-	-
Net income	(26,119)	(5,080)
Net income per common share- basic and diluted	(0.00016)	(0.00003)
Weighted average common shares outstanding - basic and diluted	163,429,806	163,429,806

4

Unaudited financial statements

BioNeutra International, Ltd.

(Formerly Supervision Entertainment, Inc.)

Statement of Stockholders' Equity (Unaudited) For the Quarter Ended July 31, 2022

	Common Stock			Additional Paid-in	Accumulated	Total stockholders'
	Shares	Amount	Treasury Stock	Capital	deficit	equity
Balance as of January 31, 2021	163,429,806	16,133	(100)	7,003,009	(7,254,254)	(235,212)
Net loss					(5,080)	(5,080)
Balance as of April 31, 2022	163,429,806	16,133	(100)	7,003,009	(7,259,334)	(240,292)
Net loss					(26,119)	(26,119)
Balance as of July 31, 2022	163,429,806	16,133	(100)	7,003,009	(7,285,453)	(266,411)

5